BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 34015796)

  • 1. Ovarian Low-grade Basaloid Carcinoma Arising in Brenner Tumor: A New Variant of Malignant Brenner Tumor.
    McGinn B; Lemaire AS; McCluggage WG
    Int J Gynecol Pathol; 2022 May; 41(3):276-284. PubMed ID: 34015796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transitional cell tumors of the ovary: a comparative clinicopathologic, immunohistochemical, and molecular genetic analysis of Brenner tumors and transitional cell carcinomas.
    Cuatrecasas M; Catasus L; Palacios J; Prat J
    Am J Surg Pathol; 2009 Apr; 33(4):556-67. PubMed ID: 19033864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brenner tumors but not transitional cell carcinomas of the ovary show urothelial differentiation: immunohistochemical staining of urothelial markers, including cytokeratins and uroplakins.
    Riedel I; Czernobilsky B; Lifschitz-Mercer B; Roth LM; Wu XR; Sun TT; Moll R
    Virchows Arch; 2001 Feb; 438(2):181-91. PubMed ID: 11253121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p63 expression in ovarian tumours: a marker for Brenner tumours but not transitional cell carcinomas.
    Liao XY; Xue WC; Shen DH; Ngan HY; Siu MK; Cheung AN
    Histopathology; 2007 Oct; 51(4):477-83. PubMed ID: 17880529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MDM2 amplification in malignant Brenner tumors may play a role in progression to malignancy and aid in separation from urothelial and other ovarian carcinomas.
    Shetty S; Habeeb O; Rivera C; Astbury C; Przybycin C; Joehlin-Price AS
    Hum Pathol; 2021 Nov; 117():42-50. PubMed ID: 34391746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Benign and malignant Brenner tumor of the ovary: a clinicopathological and immunohistochemical study].
    Peng ZN
    Zhonghua Bing Li Xue Za Zhi; 1992 Dec; 21(6):333-5. PubMed ID: 1284387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ovarian Brenner tumors and transitional cell carcinoma: recent developments.
    Roth LM; Gersell DJ; Ulbright TM
    Int J Gynecol Pathol; 1993 Apr; 12(2):128-33. PubMed ID: 8463036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malignant Brenner tumor and transitional cell carcinoma of the ovary: a comparison.
    Austin RM; Norris HJ
    Int J Gynecol Pathol; 1987; 6(1):29-39. PubMed ID: 3570630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoprofile of ovarian tumors with putative transitional cell (urothelial) differentiation using novel urothelial markers: histogenetic and diagnostic implications.
    Logani S; Oliva E; Amin MB; Folpe AL; Cohen C; Young RH
    Am J Surg Pathol; 2003 Nov; 27(11):1434-41. PubMed ID: 14576476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ovarian Brenner tumors. I. Metaplastic, proliferating, and of low malignant potential.
    Roth LM; Dallenbach-Hellweg G; Czernobilsky B
    Cancer; 1985 Aug; 56(3):582-91. PubMed ID: 4005815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transitional cell carcinoma of the ovary is related to high-grade serous carcinoma and is distinct from malignant brenner tumor.
    Ali RH; Seidman JD; Luk M; Kalloger S; Gilks CB
    Int J Gynecol Pathol; 2012 Nov; 31(6):499-506. PubMed ID: 23018212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ovarian Brenner tumors. II. Malignant.
    Roth LM; Czernobilsky B
    Cancer; 1985 Aug; 56(3):592-601. PubMed ID: 4005816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transitional cell neoplasms of the ovary and urinary bladder: a comparative immunohistochemical analysis.
    Soslow RA; Rouse RV; Hendrickson MR; Silva EG; Longacre TA
    Int J Gynecol Pathol; 1996 Jul; 15(3):257-65. PubMed ID: 8811388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three cases of an unusual pattern of invasion in malignant Brenner tumors.
    St Pierre-Robson K; Dunn PJ; Cooper E; Tofazzal N; Hirschowitz L; McCluggage WG; Ganesan R
    Int J Gynecol Pathol; 2013 Jan; 32(1):31-4. PubMed ID: 23202779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Transitional cell tumors:malignant Brenner tumor and transitional cell carcinoma of the ovary].
    Ianev N; Ivanova R; Gorchev G; Tsvetkov Ch; Veselinova T; Strateva D
    Akush Ginekol (Sofiia); 2007; 46 Suppl 2():20-22. PubMed ID: 18219757
    [No Abstract]   [Full Text] [Related]  

  • 16. [Malignant Brenner tumor and transitional cell ovarian carcinoma--description of two cases].
    Ivanova R; Veselinova T; Marinov E; Ianev N; Tsvetkov Ch; Gorchev G
    Akush Ginekol (Sofiia); 2001; 42(2):31-3. PubMed ID: 11799755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Malignant Brenner tumor and transitional cell carcinoma of the ovary].
    Guo LN; Tang MY
    Zhonghua Bing Li Xue Za Zhi; 1990 Sep; 19(3):209-11. PubMed ID: 2279315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unusual presentation of benign cystic brenner tumor with exuberant psammomatous calcifications.
    Vemavarapu L; Alatassi H; Moghadamfalahi M
    Int J Surg Pathol; 2011 Feb; 19(1):120-2. PubMed ID: 21087980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Borderline Brenner Tumor: A Review of the Literature.
    Zheng R; Heller DS
    Arch Pathol Lab Med; 2019 Oct; 143(10):1278-1280. PubMed ID: 30779594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brenner and transitional cell tumours of the ovary. Report of three cases.
    Rantanen V; Grénman S; Kiilholma P; Salmi T; Klemi PJ
    Ann Chir Gynaecol Suppl; 1994; 208():28-32. PubMed ID: 8092766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.